Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-03-000145
Filing Date
2003-01-31
Accepted
2003-01-31 16:30:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 d381141_13g-a.txt SC 13G/A 14593
  Complete submission text file 0000919574-03-000145.txt   16458
Mailing Address CURRAN PARTNERS LP 230 PARK AVENUE NEW YORK NY 1010017
Business Address CURRAN PARTNERS LP 230 PARK AVENUE NEW YORK NY 10017 2128082400
CURRAN JOHN P (Filed by) CIK: 0000026256 (see all company filings)

 

Mailing Address 2981 ROUTE 22 PATTERSON NY 12563-9970
Business Address 2981 ROUTE 22 PATTERSON NY 12563-9970 9148783414
PENWEST PHARMACEUTICALS CO (Subject) CIK: 0001047188 (see all company filings)

EIN.: 911513032 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-55303 | Film No.: 03534887
SIC: 2834 Pharmaceutical Preparations